| |
| |
|
| Insider
Information: |
Levine Mark S. |
| Relationship: |
Chief Legal Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
343,156 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
343,156 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -91.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Minerva Neurosciences, Inc. |
NERV |
SVP,General Counsel & ... |
2017-06-01 |
0 |
2017-01-04 |
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
General Counsel |
2021-11-19 |
0 |
2018-02-01 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Chief Legal Officer |
2024-04-24 |
343,156 |
2022-01-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2024-04-24 |
4 |
S |
$28.90 |
$114,531 |
D/D |
(3,963) |
343,156 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2024-04-17 |
4 |
S |
$28.80 |
$285,554 |
D/D |
(9,827) |
347,119 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,978 |
356,946 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2024-02-22 |
4 |
S |
$36.15 |
$77,144 |
D/D |
(2,134) |
301,968 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2024-01-26 |
4 |
S |
$37.91 |
$114,778 |
D/D |
(3,027) |
304,102 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-11-22 |
4 |
S |
$32.75 |
$106,598 |
D/D |
(3,252) |
307,129 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-10-25 |
4 |
S |
$34.66 |
$142,349 |
D/D |
(4,107) |
310,381 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-08-24 |
4 |
S |
$20.30 |
$249,406 |
D/D |
(12,286) |
314,488 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-07-26 |
4 |
S |
$21.63 |
$84,725 |
D/D |
(3,917) |
326,774 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-04-25 |
4 |
S |
$16.29 |
$42,892 |
D/D |
(2,633) |
330,691 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,664 |
333,324 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2023-01-26 |
4 |
S |
$18.51 |
$187,988 |
D/D |
(10,156) |
245,660 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
112,816 |
255,816 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Legal Officer |
• – – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
143,000 |
143,000 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$1,134,631 |
D/D |
(133,486) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
137,431 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2021-01-05 |
4 |
S |
$11.13 |
$76,007 |
D/D |
(6,829) |
107,431 |
0 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2020-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
38,750 |
114,260 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2020-06-22 |
4 |
A |
$10.83 |
$11,079 |
D/D |
1,023 |
75,510 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
74,487 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,724) |
43,487 |
0 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2019-06-21 |
4 |
A |
$9.81 |
$11,900 |
D/D |
1,213 |
46,273 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
45,060 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2019-01-03 |
4 |
AS |
$12.36 |
$9,072 |
D/D |
(734) |
9,060 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
General Counsel |
• – – |
2018-06-20 |
4 |
A |
$21.22 |
$11,438 |
D/D |
539 |
8,872 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
